Raydiant Oximetry is a medical device company focused on improving outcomes for mothers and babies during childbirth.
Raydiant Oximetry has raised $7.5M in total funding. The most recent round was Series A. The last funding was announced in June 2024.
Raydiant Oximetry's investors include National Science Foundation, Enterprise Ireland, March of Dimes, National Institutes of Health, FemHealth Ventures.
Raydiant Oximetry is headquartered in San Ramon, United States.
Raydiant Oximetry is a medical device company focused on improving outcomes for mothers and babies during childbirth.
Raydiant Oximetry is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Raydiant Oximetry — Funding & Investors." VCBacked, June 4, 2024, https://www.vcbacked.co/company/raydiant-oximetry. Accessed July 19, 2026.
VCBacked. (2024). Raydiant Oximetry — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/raydiant-oximetry
{{cite web |title=Raydiant Oximetry — Funding & Investors |url=https://www.vcbacked.co/company/raydiant-oximetry |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated